Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Prostratin antagonizes HIV latency by activating NF-kappaB.

Williams SA, Chen LF, Kwon H, Fenard D, Bisgrove D, Verdin E, Greene WC.

J Biol Chem. 2004 Oct 1;279(40):42008-17. Epub 2004 Jul 28.

2.

Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation.

Márquez N, Calzado MA, Sánchez-Duffhues G, Pérez M, Minassi A, Pagani A, Appendino G, Diaz L, Muñoz-Fernández MA, Muñoz E.

Biochem Pharmacol. 2008 Mar 15;75(6):1370-80. doi: 10.1016/j.bcp.2007.12.004. Epub 2007 Dec 23.

PMID:
18241838
3.

Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.

Reuse S, Calao M, Kabeya K, Guiguen A, Gatot JS, Quivy V, Vanhulle C, Lamine A, Vaira D, Demonte D, Martinelli V, Veithen E, Cherrier T, Avettand V, Poutrel S, Piette J, de Launoit Y, Moutschen M, Burny A, Rouzioux C, De Wit S, Herbein G, Rohr O, Collette Y, Lambotte O, Clumeck N, Van Lint C.

PLoS One. 2009 Jun 30;4(6):e6093. doi: 10.1371/journal.pone.0006093.

4.

Calcium/calcineurin synergizes with prostratin to promote NF-κB dependent activation of latent HIV.

Chan JK, Bhattacharyya D, Lassen KG, Ruelas D, Greene WC.

PLoS One. 2013 Oct 30;8(10):e77749. doi: 10.1371/journal.pone.0077749. eCollection 2013.

5.

Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB.

Ying H, Zhang Y, Zhou X, Qu X, Wang P, Liu S, Lu D, Zhu H.

PLoS One. 2012;7(11):e48832. doi: 10.1371/journal.pone.0048832. Epub 2012 Nov 15.

6.

Protein kinase D3 is essential for prostratin-activated transcription of integrated HIV-1 provirus promoter via NF-κB signaling pathway.

Wang H, Zhu X, Zhu Y, Liu J, Hu X, Wang Y, Peng S, Chen Y, Chen R, Ding F, Liu R.

Biomed Res Int. 2014;2014:968027. doi: 10.1155/2014/968027. Epub 2014 Jul 21.

7.

Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes.

Rullas J, Bermejo M, García-Pérez J, Beltán M, González N, Hezareh M, Brown SJ, Alcamí J.

Antivir Ther. 2004 Aug;9(4):545-54.

PMID:
15456086
8.

Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.

Biancotto A, Grivel JC, Gondois-Rey F, Bettendroffer L, Vigne R, Brown S, Margolis LB, Hirsch I.

J Virol. 2004 Oct;78(19):10507-15.

9.

Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo.

Beans EJ, Fournogerakis D, Gauntlett C, Heumann LV, Kramer R, Marsden MD, Murray D, Chun TW, Zack JA, Wender PA.

Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11698-703. doi: 10.1073/pnas.1302634110. Epub 2013 Jun 28.

11.

HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.

Saleh S, Lu HK, Evans V, Harisson D, Zhou J, Jaworowski A, Sallmann G, Cheong KY, Mota TM, Tennakoon S, Angelovich TA, Anderson J, Harman A, Cunningham A, Gray L, Churchill M, Mak J, Drummer H, Vatakis DN, Lewin SR, Cameron PU.

Retrovirology. 2016 Jul 26;13(1):49. doi: 10.1186/s12977-016-0284-7.

12.

Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.

Williams SA, Kwon H, Chen LF, Greene WC.

J Virol. 2007 Jun;81(11):6043-56. Epub 2007 Mar 21.

13.

Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

Kulkosky J, Culnan DM, Roman J, Dornadula G, Schnell M, Boyd MR, Pomerantz RJ.

Blood. 2001 Nov 15;98(10):3006-15.

14.

Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.

Rochat MA, Schlaepfer E, Speck RF.

J Virol. 2017 Jan 31;91(4). pii: e02084-16. doi: 10.1128/JVI.02084-16. Print 2017 Feb 15.

PMID:
27928016
16.

Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling.

Jiang G, Mendes EA, Kaiser P, Sankaran-Walters S, Tang Y, Weber MG, Melcher GP, Thompson GR 3rd, Tanuri A, Pianowski LF, Wong JK, Dandekar S.

AIDS. 2014 Jul 17;28(11):1555-66. doi: 10.1097/QAD.0000000000000289.

17.

Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.

Stoszko M, De Crignis E, Rokx C, Khalid MM, Lungu C, Palstra RJ, Kan TW, Boucher C, Verbon A, Dykhuizen EC, Mahmoudi T.

EBioMedicine. 2015 Nov 27;3:108-21. doi: 10.1016/j.ebiom.2015.11.047. eCollection 2016 Jan.

18.

Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.

Li C, Wang HB, Kuang WD, Ren XX, Song ST, Zhu HZ, Li Q, Xu LR, Guo HJ, Wu L, Wang JH.

J Virol. 2016 Dec 16;91(1). pii: e01830-16. Print 2017 Jan 1.

19.

HMBA Enhances Prostratin-Induced Activation of Latent HIV-1 via Suppressing the Expression of Negative Feedback Regulator A20/TNFAIP3 in NF-κB Signaling.

Chen D, Wang H, Aweya JJ, Chen Y, Chen M, Wu X, Chen X, Lu J, Chen R, Liu M.

Biomed Res Int. 2016;2016:5173205. doi: 10.1155/2016/5173205. Epub 2016 Jul 27.

20.

As2O3 synergistically reactivate latent HIV-1 by induction of NF-κB.

Wang P, Qu X, Wang X, Liu L, Zhu X, Zeng H, Zhu H.

Antiviral Res. 2013 Dec;100(3):688-97.

PMID:
24416773

Supplemental Content

Support Center